Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma
- 1 September 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (9) , 935-939
- https://doi.org/10.1053/hupa.2001.27102
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Impaired prostate tumorigenesis in Egr1-deficient miceNature Medicine, 2001
- EGR1 Target Genes in Prostate Carcinoma Cells Identified by Microarray AnalysisJournal of Biological Chemistry, 2000
- Neuroendocrine differentiation in prostatic carcinomaThe Prostate, 1999
- A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cellsProceedings of the National Academy of Sciences, 1998
- NAB2, a Corepressor of NGFI-A (Egr-1) and Krox20, Is Induced by Proliferative and Differentiative StimuliMolecular and Cellular Biology, 1996
- Increased Expression of Early Growth Response-1 Messenger Ribonucleic Acid in Prostatic AdenocarcinomaJournal of Urology, 1996
- Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription.Proceedings of the National Academy of Sciences, 1995
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995
- Early Growth Response Protein 1 (Egr-1): Prototype of a Zinc-finger Family of Transcription FactorsProgress in Nucleic Acid Research and Molecular Biology, 1995
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992